- Home
- / AMLo Biosciences
AMLo Biosciences
Total Funding
$3.2 M
AMLo Biosciences Summary
Company Summary
- Overview
- AMLo Biosciences is a company that develops a prognostic test for early-stage cutaneous melanoma. It identifies patients’ risk of disease progression.
- Type
- Private
- Status
- Active
- Founded
- 2017
- HQ
- Newcastle upon Tyne, GB | view all locations
- Cybersecurity rating
Table of Contents
Key People
Penny Lovat, Chief Scientific Officer
Jane Meaney, Marketing Director
Philip Sloan, Chief Histopathologist
LocationsView all
3 locations detected
Newcastle upon Tyne, England HQ
United Kingdom
Framlington Pl
Newcastle upon Tyne, England
United Kingdom
Gosforth Park Ave
Newcastle upon Tyne, England
United Kingdom
Newcastle Science Central Management LLP c/o, Helix, The Core